Literature DB >> 6796960

Assembly of the functional membrane attack complex of human complement: formation of disulfide-linked C9 dimers.

C F Ware, W P Kolb.   

Abstract

The 158,000 Mr protein, previously designated C5c, present in fully assembled complement (C) membrane attack complexes (MC5b-9) has been identified as a disulfide-bonded dimer of C9. This conclusion was based on the observations that: (i) a portion of the 125I-radiolabeled precursor C9 incorporated into MC5b-9 complexes comigrated with the 158,000 Mr protein band in NaDodSO4/polyacrylamide slab gels; (ii) monospecific antisera produced against native C9 and the 158,000 Mr protein immunologically crossreacted with monomeric native C9 by double immunodiffusion and with monomeric C9 and the 158,000 Mr protein on immunoreplication procedures; and (iii) two-dimensional NaDodSO4/polyacrylamide slab gel electrophoresis, in which the second dimension was conducted under reducing conditions, revealed that the 158,000 Mr protein contained two identical 71,000 Mr subunits which comigrated with monomeric C9. Molar ratio estimates indicated that 1 mol of C5b, C9 dimer, C6, C7, and C8 and 3-4 mol of C9 monomer were present per MC5b-9 complex. Each fully assembled membrane-bound MC5b-9 complex would therefore have a calculated Mr of 982,000. The presence of C9 dimers in the hemolytically active 29S dimeric form of the MC5b-9 complex and the absence of C9 dimers in the hemolytically inactive 23S monomeric form of the fluid phase SC5b-9 complex strongly suggest an important role for C9 dimer formation in MC5b-9 complex structure and function. The most probable function of C9 dimers would be the formation of intercomplex disulfide crosslinks which would provide a mechanism to stabilize the assembly of MC5b-9 into aggregates of increasing size on the target membrane surface which would thus be responsible for the observed pore size heterogeneity of functional C lesions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796960      PMCID: PMC349052          DOI: 10.1073/pnas.78.10.6426

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  The ninth component of human complement: isolation, description and mode of action.

Authors:  U Hadding; H J Müller-Eberhard
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

Review 2.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1969       Impact factor: 23.643

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Molecular biology and chemistry of the alternative pathway of complement.

Authors:  H J Müller-Eberhard; R D Schreiber
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

5.  Molecular weight of the membrane C5b-9 complex of human complement: characterization of the terminal complex as a C5b-9 monomer.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  Permeability characteristics of complement-damaged membranes: evaluation of the membrane leak generated by the complement proteins C5b-9.

Authors:  P J Sims
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

7.  Physicochemical characterization of fluid phase (SC5b-9) and membrane derived (MC5b-9) attack complexes of human complement purified by immunoadsorbent affinity chromatography or selective detergent extraction.

Authors:  C F Ware; R A Wetsel; W P Kolb
Journal:  Mol Immunol       Date:  1981-06       Impact factor: 4.407

8.  Analysis of solute diffusion across the C5b-9 membrane lesion of complement: evidence that individual C5b-9 complexes do not function as discrete, uniform pores.

Authors:  P J Sims; P K Lauf
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

9.  Membrane attack complex of complement. Evidence for its dimeric structure based on hybrid formation.

Authors:  E R Podack; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

10.  Lysis of erythrocytes by complement in the absence of antibody.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  10 in total

1.  Topology of the membrane-bound form of complement protein C9 probed by glycosylation mapping, anti-peptide antibody binding, and disulfide modification.

Authors:  Véronique Rossi; Yunxia Wang; Alfred F Esser
Journal:  Mol Immunol       Date:  2010-02-12       Impact factor: 4.407

2.  The influence of electrochemical gradients of Na+ and K+ upon the membrane binding and pore forming activity of the terminal complement proteins.

Authors:  P J Sims; T Wiedmer
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

Review 3.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

Review 4.  Activation of the complement system.

Authors:  W Vogt
Journal:  Agents Actions       Date:  1983-08

5.  Molecular composition of the terminal membrane and fluid-phase C5b-9 complexes of rabbit complement. Absence of disulphide-bonded C9 dimers in the membrane complex.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

Review 6.  C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review.

Authors:  Rand Arnaout; Sahar Al Shorbaghi; Hasan Al Dhekri; Hamoud Al-Mousa; Abdulaziz Al Ghonaium; Bandar Al Saud; Saleh Al Muhsen; Lina Al Baik; Abbas Hawwari
Journal:  J Clin Immunol       Date:  2013-02-01       Impact factor: 8.317

7.  Proteolytic modification of human complement protein C9: loss of poly(C9) and circular lesion formation without impairment of function.

Authors:  J R Dankert; A F Esser
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

8.  Terminal membrane C5b-9 complex of human complement: transition from an amphiphilic to a hydrophilic state through binding of the S protein from serum.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

9.  Glutathione inhibits antibody and complement-mediated immunologic cell injury via multiple mechanisms.

Authors:  Zhen Zhang; Xiling Zhang; Xin Fang; Manabu Niimi; Yanru Huang; Honglan Piao; Shan Gao; Jianglin Fan; Jian Yao
Journal:  Redox Biol       Date:  2017-03-31       Impact factor: 11.799

10.  Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions.

Authors:  P S Seifert; F Hugo; J Tranum-Jensen; U Zâhringer; M Muhly; S Bhakdi
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.